Related Experiment Video

Updated: Aug 30, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target

Maurice Phil DeYoung1, Matthew Tress, Ramaswamy Narayanan

  • 1Center for Molecular Biology and Biotechnology and Department of Biology, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA.

Cancer Letters
|October 11, 2003
PubMed

Insights

The Single Minded 2 gene (SIM2) shows promise as a pancreatic cancer therapy target. Inhibiting SIM2-s expression in pancreatic cancer cells significantly reduced tumor growth and induced cell death.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Pancreatic cancer has a high mortality rate.
  • The Single Minded 2 gene (SIM2), located in the Down's Syndrome Critical Region, is implicated in cancer.
  • SIM2 expression is specific to cancer cells, unlike its family member SIM1.

Purpose of the Study:

  • To investigate the therapeutic potential of the Single Minded 2 gene (SIM2) in pancreatic cancer.
  • To determine the role of SIM2 isoforms in pancreatic cancer cell proliferation and survival.

Main Methods:

  • Quantitative analysis of SIM2 gene expression in pancreatic cancer cell lines and tumor tissues versus normal pancreatic tissue.
  • Utilizing antisense technology to inhibit the expression of the SIM2 short-form (SIM2-s) isoform in CAPAN-1 cells.
  • Assessing the impact of SIM2-s inhibition on cell growth, apoptosis, and the expression of related SIM family genes.

Main Results:

  • The Single Minded 2 gene (SIM2) was significantly expressed in pancreatic cancer cell lines and tumor tissues, but not in normal pancreatic tissue.
  • Inhibition of SIM2-s expression using antisense technology led to substantial growth inhibition and apoptosis in CAPAN-1 pancreatic cancer cells.
  • The observed effects were specific to SIM2-s, as expression of related SIM family members was not affected.

Conclusions:

  • The SIM2 gene, particularly the SIM2-s isoform, represents a potential therapeutic target for pancreatic cancer.
  • Targeting SIM2-s offers a promising strategy for developing novel pancreatic cancer treatments.
  • These findings hold significant implications for improving outcomes in pancreatic cancer patients due to the gene's specific expression in tumors.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...